Acrivon Therapeutics, Inc. Common Stock Dividends
The next dividend date for Acrivon Therapeutics, Inc. Common Stock has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Acrivon Therapeutics, Inc. Common Stock (ACRV)
More About Acrivon Therapeutics, Inc. Common Stock
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 for the treatment of patients with endometrial and platinum-resistant ovarian cancer, and SCCs, such as SCCHN and anal cancer. The company is also developing ACR-2316, a dual WEE1 and PKMYT1 inhibitor small molecule candidate; and a preclinical stage AP3-and co-crystallography-based preclinical cell cycle program. Acrivon Therapeutics, Inc. was incorporated in 2018 and is based in Watertown, Massachusetts.
Owning Acrivon Therapeutics, Inc. Common Stock Stock on the Dividend Date
If you own Acrivon Therapeutics, Inc. Common Stock stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Acrivon Therapeutics, Inc. Common Stock stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Acrivon Therapeutics, Inc. Common Stock stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Acrivon Therapeutics, Inc. Common Stock stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Acrivon Therapeutics, Inc. Common Stock dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Acrivon Therapeutics, Inc. Common Stock Dividends
You can contact us any time if you would like to ask questions about Acrivon Therapeutics, Inc. Common Stock dividends or anything else related to the stock market.